Noninvasix Overview
- Founded
-
2007

- Status
-
Private
- Employees
-
4

- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$1.8M
- Investors
-
14
Noninvasix General Information
Description
Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous saturation. The company's technology monitors the severity of sepsis and septic shock and measures the amount of oxygen in the brain in real-time, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time.
Contact Information
Website
www.noninvasix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- Care of University of Texas Medical Branch
- 301 University Boulevard 2A
- Galveston, TX 77555
- United States
+1 (303) 000-0000
Noninvasix Timeline
Noninvasix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC | 06-Dec-2021 | $1.8M | 00.000 | In Progress | Generating Revenue | |
8. Seed Round | 18-Feb-2021 | 000 | 00.000 | Completed | Product Development | |
7. Seed Round | 10-Jun-2020 | 00.000 | 00.000 | 0000 | Completed | Product Development |
6. Angel (individual) | 07-Jan-2019 | Completed | Startup | |||
5. Grant | 05-Aug-2018 | 00000 | Completed | Startup | ||
4. Accelerator/Incubator | 30-Nov-2016 | Completed | Startup | |||
3. Accelerator/Incubator | 05-Sep-2015 | Completed | Startup | |||
2. Grant | 03-Jun-2015 | $6.32M | Completed | Startup | ||
1. Accelerator/Incubator | 10-Mar-2015 | Completed | Startup |
Noninvasix Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed 3 | 000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
Seed 2 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Seed 1 | 332,618 | $0.001000 | $1.02 | $1.02 | 1x | $1.02 | 3.4% | |
Seed | 1,716,051 | $0.001000 | $1.22 | $1.22 | 1x | $1.22 | 17.53% |
Noninvasix Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous satu
Monitoring Equipment
Galveston, TX
4
As of 2022
00.000
0000000000 0
00.000
Noninvasix Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000 0000000 | Corporation | San Clemente, CA | 00000 | 0000 | 000000000000 |
Noninvasix Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
David Giarracco | Chief Executive Officer & Board Member | ||
Graham Randall Ph.D | Chief Scientist and President | ||
Donald Prough MD | Co-Founder & Board Member |
Noninvasix Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Parsley | Self | Board Observer | 000 0000 |
David Giarracco | Noninvasix | Chief Executive Officer & Board Member | 000 0000 |
Donald Prough MD | Noninvasix | Co-Founder & Board Member | 000 0000 |
James Helliwell MD | Self | Board Member | 000 0000 |
Lana Caron | Self | Board Observer | 000 0000 |
Noninvasix Signals
Noninvasix Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Philips | Corporation | Minority | 000 0000 | 000000 0 | |
Green Park & Golf Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Philips Electronics North America Corporation Pension Plan | Limited Partner | Minority | 000 0000 | 000000 0 | |
Springhood | Venture Capital | Minority | 000 0000 | 000000 0 | |
Texas Ventures | PE/Buyout | Minority | 000 0000 | 000000 0 |